Are Lorlatinib and Lorlatinib the same drug?

Lorlatinib (Lorlatinib) andlorlatinib are the same anti-cancer drug, but they are transliterated differently in different contexts. This is the case because drugs often have International Nonproprietary Names (INNs) on the international market, and different countries and regions translate and transliterate them according to their language and phonetic rules to better communicate with local medical professionals and patients. It is sold under the trade name Lorbrena overseas, and after being launched domestically, it is sold under the name Lorlatinib. Lorlatinib is commonly used to treat adult patients with metastatic non-small cell lung cancer (NSCLC) who are anaplastic lymphoma kinase (ALK)-positive in a U.S. Food and Drug Administration (FDA) trial.